Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More General business news Massive Iron Dome budget boost transforms the outlook for Rimon Technologies and strengthens Nukkleus’ acquisition strategy Find out how Nukkleus’ acquisition of Rimon Technologies could accelerate growth amid a historic Iron Dome funding surge. bySoujanya RaviNovember 25, 2025